Medicinal Applications of the Cannabis Plant

A special issue of Medicines (ISSN 2305-6320).

Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 8480

Special Issue Editor


E-Mail Website
Guest Editor
Department of Psychology, University of New Mexico, Albuquerque, NM 87131, USA
Interests: Cannabis; health; well-being; chronic illness; Cannabis research; medical marijuana; tetrahydrocannabinol; cannabidiol; hemp; complementary medicine

Special Issue Information

Dear colleagues,

Recent changes in marijuana prohibition laws across many regions in the world are resulting in increasing exposure to a wide variety of commercially available pharmaceutical and recreational products derived from the Cannabis plant. Whole dried Cannabis flower is among the most frequently used type of product, yet there remains a dearth of scientific research on the risks and benefits of using common and commercially available Cannabis flower and associated retail products. We are seeking research that can elucidate the medicinal applications and potential risks of consuming Cannabis flower and its derivatives for therapeutic purposes.

This Special Issue aims to provide a collective body of research specifically focused on the benefits and risks of conventional consumption of the Cannabis plant, rather than synthetic analogues and formulates commonly used in clinical trials. We are interested in both experimental and observational research designs, which are particularly useful for measuring the real-world effects of consuming the wide range of available plant strains and plant-derived products, which typically vary from batch-to-batch in their chemotypic properties due to the heterogenetic nature of all phytomedicines, including the Cannabis plant.

Furthermore, there is also a need for a better understanding of how effects from Cannabis consumption vary by individual or subgroup (e.g., across biological, demographic, or health conditions) in order to guide more personalized therapeutic treatments.

We are interested in scientific contributions from all fields of Cannabis research. We are particularly interested in researchers measuring the effects of consuming the natural Cannabis plant and derived products.

Topics of interest include:

Cannabis use and pain;
Cannabis use and mental health;
Cannabis use pharmacodynamics;
Cannabis use and cancer;
Cannabis use and general health;
Cannabis use and chronic illness;
Cannabis use and general well-being;
• Individual differences in Cannabis effects;
• Benefits and risks of commercially available Cannabis products.

Dr. Jacob M. Vigil
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Cannabis
  • health
  • well-being
  • chronic illness
  • Cannabis research

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

6 pages, 390 KiB  
Article
Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils
by Masashi Kitamura, Yuka Kiba, Ryuichiro Suzuki, Natsumi Tomida, Akemi Uwaya, Fumiyuki Isami and Shixin Deng
Medicines 2020, 7(9), 57; https://doi.org/10.3390/medicines7090057 - 7 Sep 2020
Cited by 16 | Viewed by 7980
Abstract
Background: Hemp (Cannabis sativa L.) seed contains high contents of various nutrients, including fatty acids and proteins. Cannabidiol (CBD) is a non-psychoactive compound that can be extracted from C. sativa and used for treating epilepsy and pain. Industrial hemp products, including CBD [...] Read more.
Background: Hemp (Cannabis sativa L.) seed contains high contents of various nutrients, including fatty acids and proteins. Cannabidiol (CBD) is a non-psychoactive compound that can be extracted from C. sativa and used for treating epilepsy and pain. Industrial hemp products, including CBD and hemp seed oils, have become increasingly popular. Some products are marketed without a clear distinction between CBD and hemp seed oils. Herein, the CBD content and biological activities of commercial CBD and hemp seed oils were examined. Methods: CBD content was measured by high-performance liquid chromatography. For in vitro antioxidant activity determination, 2,2-diphenyl-1-picrylhydrazyl and 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) radical-scavenging assays were performed. Results: The CBD concentrations in the two CBD oil samples were 18.9 ± 0.5 and 9.2 ± 0.4 mg/mL. Of the seven hemp seed oil samples, six samples contained CBD in concentrations ranging from 2.0 ± 0.1 to 20.5 ± 0.5 µg/mL, but it was not detected in one sample. Antioxidant activity was observed in both CBD oil samples. Conclusions: The results indicate that (1) CBD content varied by hemp seed oil sample and that (2) antioxidant activity could be a useful landmark for discriminating CBD oils from hemp seed oils. Full article
(This article belongs to the Special Issue Medicinal Applications of the Cannabis Plant)
Show Figures

Figure 1

Back to TopTop